Annexon (ANNX) Assets Average (2020 - 2026)
Annexon's (ANNX) quarterly Assets Average came in at $270.2 million in Q1 2026, down 17.25% year-on-year from $326.5 million in Q1 2025, and up 6.66% quarter-over-quarter from $253.4 million in Q4 2025.
Annexon (ANNX) Assets Average (2020 - 2026) Analysis & Trends
Annexon's Assets Average history runs 7 years deep, the most recent figure standing at $270.2 million for Q1 2026.
- On a quarterly basis, Assets Average fell 17.25% year-over-year to $270.2 million in Q1 2026; TTM through Mar 2026 was $270.2 million, a 17.25% decrease from a year earlier, with the FY2025 full-year figure at $313.8 million, down 3.1% from the prior year.
- Assets Average rose to $270.2 million in Q1 2026 per ANNX's latest filing, from $253.4 million in the prior quarter.
- Across five years, Assets Average topped out at $392.4 million in Q3 2024 and bottomed at $218.4 million in Q3 2023.
- The 5-year median for Assets Average is $270.2 million (2026), against an average of $285.9 million.
- Across the five-year window, Assets Average jumped 79.67% in 2024 and sank 37.1% in 2025, its largest moves.
- Year by year, Assets Average stood at $298.9 million in 2022, then declined by 16.11% to $250.7 million in 2023, then surged by 45.34% to $364.4 million in 2024, then sank by 30.48% to $253.4 million in 2025, then climbed by 6.66% to $270.2 million in 2026.
- Per Business Quant, the three latest ANNX Assets Average figures stand at $270.2 million (Q1 2026), $253.4 million (Q4 2025), and $246.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.30 Bn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | 270.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270.23 Mn |
| Dec 31, 2025 | 253.36 Mn |
| Sep 30, 2025 | 246.86 Mn |
| Jun 30, 2025 | 283.80 Mn |
| Mar 31, 2025 | 326.55 Mn |
| Dec 31, 2024 | 364.42 Mn |
| Sep 30, 2024 | 392.43 Mn |
| Jun 30, 2024 | 355.08 Mn |
| Mar 31, 2024 | 300.87 Mn |
| Dec 31, 2023 | 250.75 Mn |
| Sep 30, 2023 | 218.41 Mn |
| Jun 30, 2023 | 250.90 Mn |
| Mar 31, 2023 | 276.94 Mn |
| Dec 31, 2022 | 298.91 Mn |
| Sep 30, 2022 | 266.71 Mn |
| Jun 30, 2022 | 235.64 Mn |
| Mar 31, 2022 | 268.80 Mn |
| Dec 31, 2021 | 298.60 Mn |
| Sep 30, 2021 | 320.97 Mn |
| Jun 30, 2021 | 332.45 Mn |